Engitix is a tissue engineering company that develops tissue and disease-specific human extracellular matrix for drug discovery process. Engitix was founded in 2016. Engitix's headquarters is located in London, England, GB NW32PF.
Engitix's Co-Founder & CEO, Giuseppe Mazza, currently has an approval
rating of 70%. Engitix's primary competitors are
There are no competitors identified for Engitix
There have been no acquisitions found related to Engitix
Recent investment data cannot be found related to Engitix